LISI GROUP - 2018 Financial report

22 / 171

DENTAL IMPLANTS
MINIMALLY INVASIVE
SURGERY INSTRUMENTS
INSTRUMENTS
VASCULAR
IMPLANTS
UPPER EXTREMITIES
IMPLANTS
MAXILLOFACIAL IMPLANTS
TRAUMATOLOGY
IMPLANTS
TOTAL KNEE
PROSTHESIS
LOWER EXTREMITIES
IMPLANTS
SPINAL
IMPLANTS
TOTAL HIP
PROSTHESIS
UPPER EXTREMITIES
IMPLANTS
1.3 ILISI MEDICAL
€130.7 million
SALES REVENUE
8%of consolidated sales revenue
959
STAFF
8%of Group headcount
€10.6 million
CAPEX
8%of total Group CAPEX
Activity
Medical implant and auxiliary
parts subcontractor
Flagship products
Orthopedics and
osteosynthesis;
Hip;
Knee;
Shoulder;
Spine;
Trauma;
Extremities;
OMFS;
Orthopedic instruments.
Advanced surgical technologies:
Cardiovascular;
Urology;
Manual and robotic laparoscopy.
Customers
Ace Surgical;
Alphatec;
Argen;
Boston Scientific;
Coloplast;
Integra Lifescience;
Intuitive surgical;
Johnson & Johnson subsidiaries;
Medacta;
Medicrea;
Medtronic;
Meril;
Next Ortho;
Osd;
Osteocentric Technologies;
Smiths;
Stryker;
Wright Medical;
Zimmer-Biomet.
Competitors
Avalign;
CeramTec;
Freudenberg Medical;
Integer;
Marle;
NN Inc;
Norwood;
Orchid;
TE Connectivity (Creganna);
Tecomet;
Viant.
LISI MEDICAL is involved in the design, manufacturing and marketing phases of all above-mentioned products. LISI MEDICAL is positioned as a
subcontractor.
Themain rawmaterials used are the following: titanium, chromium, cobalt, plastic (PEEK, PEHT), etc.
Themain technologies used are turning, milling, forging, packaging under sterile conditions, laser marking and special processes.